METTL3 and esophageal squamous cell carcinoma: Our study demonstrates that upregulated METTL3 is associated with proliferation and metastasis of ESCC through COL12A1/MAPK pathway, suggesting METTL3 has an oncogenic role and may indicate a potential biomarker panel for prognostic prediction in ESCC.